Benzinga | Sep 30, 2020 08:13AM EDT

Fulgent Genetics Announces Partnership with Ohio Department of Rehabilitation and Correction for COVID-19 Testing

Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent Genetics" or the "company"), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that the Ohio Department of Rehabilitation and Correction ("ODRC") has selected Fulgent Genetics for their COVID-19 testing needs.

The Ohio Department of Rehabilitation and Correction will leverage Fulgent's RT-PCR testing capabilities and Enterprise Platform to test its approximately 14,000 employees on a routine basis. The partnership encompasses on-site testing at locations across the state and will leverage Fulgent's Enterprise Platform. Fulgent's platform will enable the ODRC to streamline the on-site testing process by either giving each employee a QR code or using their employer ID which is linked to the individual's sample via a barcode scan, and then self-collected under supervision and returned to Fulgent's lab for processing and reporting. Employees will receive their results within 24 hours of sample receipt.

"We look forward to aiding the Ohio Department of Rehabilitation and Correction in their effort to protect their employees and curb the spread of COVID-19 across their facilities," commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. "Our Enterprise Platform offering enables the ODRC to test their employees in an extremely efficient manner, a process that takes approximately one minute per person. This offering provides a flexible and comprehensive testing solution for the ODRC that utilizes our gold-standard RT-PCR testing capabilities. Fulgent continues to raise the bar in offering COVID-19 testing solutions that meet the needs of large organizations and municipalities in a highly efficient and accurate manner."